William Seth Stone, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Psychotic Disorders | 60 | 2024 | 3193 | 4.920 |
Why?
|
Schizophrenia | 84 | 2024 | 6915 | 3.670 |
Why?
|
Schizophrenic Psychology | 34 | 2024 | 1646 | 2.100 |
Why?
|
Endophenotypes | 23 | 2023 | 255 | 1.750 |
Why?
|
Schizotypal Personality Disorder | 7 | 2012 | 290 | 1.050 |
Why?
|
Neuropsychological Tests | 43 | 2024 | 7021 | 0.890 |
Why?
|
Social Adjustment | 4 | 2021 | 632 | 0.790 |
Why?
|
Multilingualism | 1 | 2021 | 87 | 0.740 |
Why?
|
Cognition | 14 | 2024 | 6957 | 0.730 |
Why?
|
Antipsychotic Agents | 10 | 2022 | 3061 | 0.710 |
Why?
|
Verbal Learning | 7 | 2022 | 462 | 0.700 |
Why?
|
China | 13 | 2020 | 2339 | 0.700 |
Why?
|
Memory, Short-Term | 9 | 2020 | 978 | 0.700 |
Why?
|
Family | 16 | 2016 | 3189 | 0.650 |
Why?
|
Memory Disorders | 6 | 2013 | 1197 | 0.610 |
Why?
|
Cognition Disorders | 17 | 2023 | 3976 | 0.560 |
Why?
|
Psychiatric Status Rating Scales | 20 | 2023 | 6015 | 0.500 |
Why?
|
Longitudinal Studies | 28 | 2024 | 14495 | 0.470 |
Why?
|
Disease Progression | 13 | 2024 | 13502 | 0.470 |
Why?
|
Psychological Tests | 1 | 2016 | 639 | 0.440 |
Why?
|
Siblings | 6 | 2015 | 824 | 0.440 |
Why?
|
Adolescent | 70 | 2024 | 87810 | 0.420 |
Why?
|
Affective Disorders, Psychotic | 3 | 2021 | 186 | 0.400 |
Why?
|
Young Adult | 53 | 2024 | 58741 | 0.380 |
Why?
|
Risperidone | 2 | 2012 | 379 | 0.370 |
Why?
|
Hippocampus | 3 | 2023 | 3738 | 0.360 |
Why?
|
Glucose | 6 | 2014 | 4351 | 0.320 |
Why?
|
Humans | 137 | 2024 | 760621 | 0.310 |
Why?
|
Adult | 75 | 2024 | 219994 | 0.290 |
Why?
|
Memory | 7 | 2021 | 2179 | 0.290 |
Why?
|
Verbal Behavior | 2 | 2007 | 335 | 0.280 |
Why?
|
Auditory Perception | 3 | 2016 | 580 | 0.270 |
Why?
|
Tobacco Use Disorder | 1 | 2012 | 700 | 0.270 |
Why?
|
Male | 81 | 2024 | 359744 | 0.260 |
Why?
|
Neural Inhibition | 3 | 2017 | 589 | 0.260 |
Why?
|
Genetic Predisposition to Disease | 22 | 2015 | 17790 | 0.260 |
Why?
|
Saccades | 3 | 2014 | 233 | 0.250 |
Why?
|
Attention | 9 | 2024 | 2387 | 0.250 |
Why?
|
Risk | 12 | 2024 | 9631 | 0.240 |
Why?
|
Mental Recall | 7 | 2014 | 1206 | 0.240 |
Why?
|
Acoustic Stimulation | 7 | 2020 | 1232 | 0.240 |
Why?
|
Nerve Net | 3 | 2021 | 2261 | 0.240 |
Why?
|
Diffusion Magnetic Resonance Imaging | 4 | 2024 | 2782 | 0.230 |
Why?
|
Hydrocortisone | 2 | 2023 | 1803 | 0.230 |
Why?
|
Cholinergic Antagonists | 2 | 2023 | 164 | 0.230 |
Why?
|
Glucose Solution, Hypertonic | 1 | 2003 | 10 | 0.230 |
Why?
|
Female | 81 | 2024 | 391270 | 0.230 |
Why?
|
Evoked Potentials, Auditory | 3 | 2014 | 529 | 0.220 |
Why?
|
Case-Control Studies | 15 | 2020 | 22053 | 0.220 |
Why?
|
Event-Related Potentials, P300 | 2 | 2014 | 149 | 0.220 |
Why?
|
Syndrome | 4 | 2020 | 3280 | 0.220 |
Why?
|
Brain | 16 | 2024 | 26951 | 0.210 |
Why?
|
North America | 6 | 2022 | 1284 | 0.210 |
Why?
|
Enzymes | 1 | 2004 | 261 | 0.210 |
Why?
|
Delusions | 2 | 2022 | 298 | 0.210 |
Why?
|
Narcolepsy | 2 | 2016 | 199 | 0.210 |
Why?
|
Theory of Mind | 1 | 2024 | 91 | 0.200 |
Why?
|
Lupus Vasculitis, Central Nervous System | 1 | 2022 | 32 | 0.200 |
Why?
|
Language | 2 | 2021 | 1533 | 0.200 |
Why?
|
Cerebellar Nuclei | 1 | 2021 | 51 | 0.190 |
Why?
|
Temporal Lobe | 3 | 2007 | 1688 | 0.190 |
Why?
|
Smoking | 5 | 2015 | 9073 | 0.190 |
Why?
|
Complement System Proteins | 1 | 2024 | 782 | 0.180 |
Why?
|
Glycolysis | 1 | 2004 | 828 | 0.170 |
Why?
|
Family Therapy | 1 | 2021 | 213 | 0.170 |
Why?
|
Clozapine | 1 | 2003 | 506 | 0.170 |
Why?
|
Stress, Psychological | 3 | 2023 | 4446 | 0.170 |
Why?
|
Psychometrics | 5 | 2020 | 3051 | 0.160 |
Why?
|
Hallucinations | 1 | 2022 | 366 | 0.160 |
Why?
|
Time Factors | 2 | 2020 | 40165 | 0.160 |
Why?
|
Reference Values | 6 | 2016 | 4925 | 0.150 |
Why?
|
Prefrontal Cortex | 2 | 2007 | 2212 | 0.150 |
Why?
|
Social Behavior Disorders | 2 | 2017 | 96 | 0.150 |
Why?
|
Middle Aged | 41 | 2021 | 220352 | 0.150 |
Why?
|
Cluster Analysis | 4 | 2012 | 2698 | 0.150 |
Why?
|
Auditory Perceptual Disorders | 1 | 2017 | 36 | 0.140 |
Why?
|
Environment | 5 | 2013 | 1118 | 0.140 |
Why?
|
Independent Living | 1 | 2020 | 570 | 0.130 |
Why?
|
Cannabis | 1 | 2022 | 436 | 0.130 |
Why?
|
Remission Induction | 1 | 2022 | 2392 | 0.130 |
Why?
|
Minority Groups | 1 | 2023 | 1201 | 0.130 |
Why?
|
Phenotype | 8 | 2010 | 16546 | 0.130 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 2020 | 700 | 0.130 |
Why?
|
Task Performance and Analysis | 2 | 2017 | 759 | 0.130 |
Why?
|
Basal Metabolism | 1 | 2016 | 161 | 0.130 |
Why?
|
Risk Factors | 20 | 2023 | 74359 | 0.120 |
Why?
|
Gait Disorders, Neurologic | 1 | 2017 | 238 | 0.120 |
Why?
|
Analysis of Variance | 6 | 2017 | 6238 | 0.120 |
Why?
|
Epidemiologic Research Design | 2 | 2015 | 368 | 0.120 |
Why?
|
Suicidal Ideation | 1 | 2024 | 1425 | 0.120 |
Why?
|
Paternal Age | 1 | 2014 | 87 | 0.110 |
Why?
|
Sensory Gating | 1 | 2014 | 47 | 0.110 |
Why?
|
Depression | 2 | 2020 | 8044 | 0.110 |
Why?
|
Cerebral Cortex | 5 | 2024 | 5761 | 0.110 |
Why?
|
Speech Perception | 2 | 2014 | 505 | 0.110 |
Why?
|
Sex Differentiation | 1 | 2013 | 73 | 0.110 |
Why?
|
Models, Psychological | 1 | 2017 | 827 | 0.100 |
Why?
|
Internal-External Control | 1 | 2014 | 359 | 0.100 |
Why?
|
Genetics, Behavioral | 1 | 2012 | 53 | 0.100 |
Why?
|
Peer Group | 1 | 2017 | 674 | 0.100 |
Why?
|
Child | 13 | 2023 | 79806 | 0.100 |
Why?
|
Schizoid Personality Disorder | 1 | 2010 | 14 | 0.090 |
Why?
|
California | 1 | 2014 | 1416 | 0.090 |
Why?
|
Proteomics | 1 | 2024 | 3817 | 0.090 |
Why?
|
Rural Population | 1 | 2020 | 2268 | 0.090 |
Why?
|
Sex Factors | 4 | 2023 | 10547 | 0.090 |
Why?
|
Interpersonal Relations | 1 | 2017 | 1428 | 0.090 |
Why?
|
Evoked Potentials | 1 | 2015 | 1036 | 0.080 |
Why?
|
Cohort Studies | 6 | 2021 | 41335 | 0.080 |
Why?
|
Emotions | 2 | 2012 | 2734 | 0.080 |
Why?
|
Double-Blind Method | 4 | 2012 | 12427 | 0.080 |
Why?
|
Pilot Projects | 6 | 2017 | 8555 | 0.080 |
Why?
|
Cooperative Behavior | 2 | 2006 | 1500 | 0.080 |
Why?
|
Magnetic Resonance Imaging | 13 | 2024 | 36290 | 0.080 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2022 | 2159 | 0.080 |
Why?
|
Lod Score | 2 | 2013 | 602 | 0.080 |
Why?
|
Nuclear Family | 2 | 2014 | 313 | 0.080 |
Why?
|
Psychomotor Performance | 2 | 2014 | 1878 | 0.080 |
Why?
|
Family Health | 2 | 2012 | 1257 | 0.080 |
Why?
|
Wechsler Scales | 2 | 2013 | 257 | 0.080 |
Why?
|
Cholecalciferol | 1 | 2013 | 550 | 0.080 |
Why?
|
Mental Disorders | 3 | 2024 | 6796 | 0.080 |
Why?
|
Cross-Over Studies | 2 | 2005 | 2061 | 0.080 |
Why?
|
Self Concept | 1 | 2014 | 1039 | 0.080 |
Why?
|
Substance-Related Disorders | 2 | 2022 | 4371 | 0.070 |
Why?
|
Age Factors | 4 | 2023 | 18416 | 0.070 |
Why?
|
Depressive Disorder, Major | 2 | 2020 | 4744 | 0.070 |
Why?
|
Developing Countries | 1 | 2020 | 2868 | 0.070 |
Why?
|
Genome-Wide Association Study | 2 | 2019 | 12626 | 0.070 |
Why?
|
Genotype | 5 | 2013 | 12960 | 0.070 |
Why?
|
Bipolar Disorder | 1 | 2024 | 5078 | 0.070 |
Why?
|
Hypercholesterolemia | 1 | 2013 | 1155 | 0.070 |
Why?
|
Risk Assessment | 4 | 2022 | 24123 | 0.070 |
Why?
|
Disease Susceptibility | 3 | 2021 | 1791 | 0.070 |
Why?
|
Aged | 19 | 2021 | 169152 | 0.060 |
Why?
|
Mental Processes | 1 | 2007 | 245 | 0.060 |
Why?
|
Body Weight | 1 | 2016 | 4611 | 0.060 |
Why?
|
Water | 2 | 2024 | 1407 | 0.060 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2021 | 3701 | 0.060 |
Why?
|
Inheritance Patterns | 1 | 2007 | 340 | 0.060 |
Why?
|
Social Behavior | 1 | 2012 | 1131 | 0.060 |
Why?
|
Chromosome Mapping | 3 | 2004 | 4625 | 0.060 |
Why?
|
Psychology | 1 | 2007 | 355 | 0.060 |
Why?
|
Pedigree | 4 | 2007 | 4578 | 0.060 |
Why?
|
DNA Methylation | 2 | 2012 | 4373 | 0.060 |
Why?
|
Phosphofructokinase-1 | 1 | 2004 | 51 | 0.060 |
Why?
|
Multicenter Studies as Topic | 2 | 2006 | 1722 | 0.060 |
Why?
|
Phosphofructokinase-2 | 1 | 2004 | 32 | 0.060 |
Why?
|
Hexokinase | 1 | 2004 | 125 | 0.060 |
Why?
|
Role | 1 | 2024 | 177 | 0.060 |
Why?
|
Saccharin | 1 | 2003 | 20 | 0.060 |
Why?
|
Vitamin D Deficiency | 1 | 2013 | 1379 | 0.060 |
Why?
|
Terminology as Topic | 2 | 2001 | 1535 | 0.060 |
Why?
|
Telemedicine | 1 | 2021 | 3018 | 0.050 |
Why?
|
Genetic Linkage | 3 | 2004 | 2381 | 0.050 |
Why?
|
Cerebellum | 1 | 2010 | 1496 | 0.050 |
Why?
|
Association Learning | 1 | 2005 | 219 | 0.050 |
Why?
|
Aging | 1 | 2022 | 8651 | 0.050 |
Why?
|
Linear Models | 3 | 2020 | 5877 | 0.050 |
Why?
|
Severity of Illness Index | 6 | 2015 | 15840 | 0.050 |
Why?
|
Prognosis | 5 | 2024 | 29658 | 0.050 |
Why?
|
Pyruvate Kinase | 1 | 2004 | 190 | 0.050 |
Why?
|
Anesthesiology | 1 | 2012 | 1116 | 0.050 |
Why?
|
Blood Coagulation Factors | 1 | 2024 | 365 | 0.050 |
Why?
|
Follow-Up Studies | 5 | 2024 | 39261 | 0.050 |
Why?
|
Genetic Association Studies | 1 | 2011 | 2717 | 0.050 |
Why?
|
Social Environment | 1 | 2006 | 1022 | 0.050 |
Why?
|
Social Participation | 1 | 2023 | 183 | 0.050 |
Why?
|
Feasibility Studies | 2 | 2014 | 5201 | 0.050 |
Why?
|
Psychopathology | 1 | 2024 | 429 | 0.050 |
Why?
|
Transcranial Magnetic Stimulation | 1 | 2010 | 1469 | 0.050 |
Why?
|
Radionuclide Imaging | 1 | 2005 | 1975 | 0.050 |
Why?
|
Electroencephalography | 5 | 2015 | 6189 | 0.040 |
Why?
|
Dietary Supplements | 1 | 2013 | 3392 | 0.040 |
Why?
|
Genetic Markers | 1 | 2006 | 2608 | 0.040 |
Why?
|
Neuregulins | 1 | 2019 | 36 | 0.040 |
Why?
|
Mood Disorders | 1 | 2006 | 1124 | 0.040 |
Why?
|
Adaptation, Psychological | 1 | 2010 | 2628 | 0.040 |
Why?
|
Acoustics | 1 | 2020 | 242 | 0.040 |
Why?
|
Models, Genetic | 2 | 2006 | 3442 | 0.040 |
Why?
|
Organ Size | 1 | 2023 | 2254 | 0.040 |
Why?
|
Technology | 1 | 2021 | 291 | 0.040 |
Why?
|
Photic Stimulation | 1 | 2005 | 1967 | 0.040 |
Why?
|
Personality Inventory | 2 | 2012 | 1018 | 0.040 |
Why?
|
Schizophrenia, Paranoid | 1 | 1998 | 102 | 0.040 |
Why?
|
Functional Laterality | 1 | 2005 | 2253 | 0.040 |
Why?
|
Multivariate Analysis | 3 | 2019 | 12159 | 0.040 |
Why?
|
Prospective Studies | 4 | 2024 | 54303 | 0.040 |
Why?
|
Arousal | 2 | 2015 | 1157 | 0.040 |
Why?
|
Predictive Value of Tests | 4 | 2019 | 15289 | 0.040 |
Why?
|
International Cooperation | 1 | 2024 | 1433 | 0.040 |
Why?
|
Behavioral Symptoms | 1 | 1999 | 185 | 0.040 |
Why?
|
Extracellular Space | 1 | 2019 | 564 | 0.040 |
Why?
|
Comorbidity | 1 | 2012 | 10551 | 0.040 |
Why?
|
Contingent Negative Variation | 1 | 2017 | 36 | 0.040 |
Why?
|
Potassium Channels | 1 | 2019 | 534 | 0.030 |
Why?
|
Administration, Oral | 1 | 2005 | 4035 | 0.030 |
Why?
|
Corpus Callosum | 1 | 2021 | 749 | 0.030 |
Why?
|
Calorimetry, Indirect | 1 | 2016 | 174 | 0.030 |
Why?
|
Gene Expression Profiling | 1 | 2011 | 9411 | 0.030 |
Why?
|
Saliva | 1 | 2020 | 820 | 0.030 |
Why?
|
Therapy, Computer-Assisted | 1 | 2017 | 267 | 0.030 |
Why?
|
Blood-Brain Barrier | 1 | 2022 | 1019 | 0.030 |
Why?
|
Eye Movement Measurements | 1 | 2014 | 31 | 0.030 |
Why?
|
Prevalence | 1 | 2012 | 15687 | 0.030 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2024 | 1079 | 0.030 |
Why?
|
Cross-Sectional Studies | 3 | 2022 | 25942 | 0.030 |
Why?
|
Clinical Trials as Topic | 1 | 2011 | 8056 | 0.030 |
Why?
|
Epilepsy, Temporal Lobe | 1 | 1998 | 387 | 0.030 |
Why?
|
CpG Islands | 2 | 2012 | 1221 | 0.030 |
Why?
|
Patient Selection | 1 | 2006 | 4283 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2020 | 14660 | 0.030 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 1 | 2020 | 1988 | 0.030 |
Why?
|
Social Stigma | 1 | 2020 | 734 | 0.030 |
Why?
|
Drug Therapy, Combination | 1 | 2003 | 6498 | 0.030 |
Why?
|
Disorders of Excessive Somnolence | 1 | 2016 | 277 | 0.030 |
Why?
|
Multifactorial Inheritance | 1 | 2021 | 1365 | 0.030 |
Why?
|
Reproducibility of Results | 3 | 2018 | 20080 | 0.030 |
Why?
|
Computers | 1 | 2015 | 595 | 0.030 |
Why?
|
Factor Analysis, Statistical | 1 | 2015 | 998 | 0.030 |
Why?
|
Nervous System Diseases | 1 | 2002 | 1647 | 0.020 |
Why?
|
Hand Strength | 1 | 2014 | 452 | 0.020 |
Why?
|
Socioeconomic Factors | 2 | 2014 | 7806 | 0.020 |
Why?
|
Down Syndrome | 1 | 1998 | 892 | 0.020 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2014 | 448 | 0.020 |
Why?
|
Reaction Time | 2 | 2006 | 2075 | 0.020 |
Why?
|
Genetic Pleiotropy | 1 | 2011 | 181 | 0.020 |
Why?
|
Diagnosis, Differential | 2 | 2002 | 12965 | 0.020 |
Why?
|
Brain Mapping | 1 | 2005 | 6568 | 0.020 |
Why?
|
Disability Evaluation | 1 | 2017 | 1826 | 0.020 |
Why?
|
Happiness | 1 | 2010 | 170 | 0.020 |
Why?
|
Neck Pain | 1 | 2010 | 186 | 0.020 |
Why?
|
Epistasis, Genetic | 1 | 2011 | 350 | 0.020 |
Why?
|
Theta Rhythm | 1 | 2010 | 217 | 0.020 |
Why?
|
Serial Learning | 1 | 2008 | 41 | 0.020 |
Why?
|
ROC Curve | 1 | 2016 | 3568 | 0.020 |
Why?
|
United States | 3 | 2012 | 72461 | 0.020 |
Why?
|
Databases, Factual | 1 | 2024 | 8035 | 0.020 |
Why?
|
Research Design | 1 | 2024 | 6180 | 0.020 |
Why?
|
Nucleosomes | 1 | 2011 | 484 | 0.020 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2013 | 707 | 0.020 |
Why?
|
Fasting | 1 | 2014 | 1603 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2019 | 3562 | 0.020 |
Why?
|
Massachusetts | 2 | 2013 | 8803 | 0.020 |
Why?
|
Body Mass Index | 2 | 2016 | 12914 | 0.020 |
Why?
|
Communication | 1 | 2021 | 3849 | 0.020 |
Why?
|
Body Composition | 1 | 2016 | 2419 | 0.020 |
Why?
|
Age of Onset | 1 | 2014 | 3301 | 0.020 |
Why?
|
Sample Size | 1 | 2010 | 840 | 0.020 |
Why?
|
Visual Perception | 1 | 2015 | 1374 | 0.020 |
Why?
|
Weight Gain | 1 | 2016 | 2347 | 0.020 |
Why?
|
Genetic Research | 1 | 2006 | 172 | 0.020 |
Why?
|
Color Perception | 1 | 2006 | 212 | 0.020 |
Why?
|
Neuroprotective Agents | 1 | 2012 | 961 | 0.020 |
Why?
|
Regression Analysis | 1 | 2015 | 6360 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2010 | 1180 | 0.020 |
Why?
|
Child, Preschool | 2 | 2021 | 42063 | 0.020 |
Why?
|
Orientation | 1 | 2006 | 321 | 0.020 |
Why?
|
Universities | 1 | 2010 | 992 | 0.020 |
Why?
|
Psychotropic Drugs | 1 | 2010 | 883 | 0.010 |
Why?
|
Leukocytes | 1 | 2012 | 2026 | 0.010 |
Why?
|
Executive Function | 1 | 2013 | 1374 | 0.010 |
Why?
|
New York | 1 | 2006 | 875 | 0.010 |
Why?
|
Blood Glucose | 2 | 2014 | 6381 | 0.010 |
Why?
|
Anisotropy | 1 | 2007 | 1278 | 0.010 |
Why?
|
Interviews as Topic | 1 | 2011 | 2659 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2011 | 3775 | 0.010 |
Why?
|
Headache | 1 | 2010 | 1249 | 0.010 |
Why?
|
Influenza, Human | 1 | 2014 | 1528 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2013 | 15789 | 0.010 |
Why?
|
Research Support as Topic | 1 | 2006 | 699 | 0.010 |
Why?
|
Overweight | 1 | 2013 | 2421 | 0.010 |
Why?
|
Personality Disorders | 1 | 2006 | 721 | 0.010 |
Why?
|
Parents | 1 | 2015 | 3549 | 0.010 |
Why?
|
Activities of Daily Living | 1 | 2011 | 2417 | 0.010 |
Why?
|
Artifacts | 1 | 2010 | 1898 | 0.010 |
Why?
|
Logistic Models | 1 | 2016 | 13314 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2012 | 5785 | 0.010 |
Why?
|
Histones | 1 | 2011 | 2583 | 0.010 |
Why?
|
Twin Studies as Topic | 1 | 2001 | 104 | 0.010 |
Why?
|
Observer Variation | 1 | 2006 | 2601 | 0.010 |
Why?
|
Chronic Disease | 1 | 2015 | 9287 | 0.010 |
Why?
|
Volition | 1 | 1999 | 62 | 0.010 |
Why?
|
Diseases in Twins | 1 | 2001 | 447 | 0.010 |
Why?
|
Obstetric Labor Complications | 1 | 2001 | 236 | 0.010 |
Why?
|
Paired-Associate Learning | 1 | 1998 | 53 | 0.010 |
Why?
|
Genetic Testing | 1 | 2011 | 3531 | 0.010 |
Why?
|
Mental Status Schedule | 1 | 1998 | 314 | 0.010 |
Why?
|
Data Collection | 1 | 2006 | 3315 | 0.010 |
Why?
|
Consensus | 1 | 2007 | 3113 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2011 | 12766 | 0.010 |
Why?
|
Neural Pathways | 1 | 2007 | 3040 | 0.010 |
Why?
|
Mutation | 2 | 2014 | 29932 | 0.010 |
Why?
|
Anxiety | 1 | 2010 | 4538 | 0.010 |
Why?
|
Blood Pressure | 1 | 2010 | 8525 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2014 | 80372 | 0.010 |
Why?
|
Obesity | 1 | 2016 | 12922 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2014 | 26181 | 0.010 |
Why?
|
Psychiatry | 1 | 2004 | 1689 | 0.010 |
Why?
|
Infant | 1 | 2014 | 36060 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2007 | 8950 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2012 | 15697 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2010 | 65017 | 0.010 |
Why?
|
Quality of Life | 1 | 2011 | 13308 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2004 | 11903 | 0.000 |
Why?
|
Dose-Response Relationship, Drug | 1 | 1998 | 10827 | 0.000 |
Why?
|
Animals | 1 | 2012 | 167963 | 0.000 |
Why?
|
Pregnancy | 1 | 2001 | 29749 | 0.000 |
Why?
|
Aged, 80 and over | 1 | 1998 | 58995 | 0.000 |
Why?
|